Cefpodoxime Proxetil
Product Description
Deva Holding A.S.
-
TR -
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Categories
Deva Holding A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
More Products from Deva Holding A.S. (99)
-
Product Cefdinir
300 mg Capsule -
Product Cefdinir
125 mg/5 ml, 250 mg/5 ml Powder for Oral Suspension -
Product Cefixime Trihydrate
400 mg Film Coated Tablet -
Product Cefixime Trihydrate
400 mg Dispersable Tablet -
Product Cefixime Trihydrate
100 mg/5 ml, 50 ml and 100 ml Powder for Oral Suspension -
Product Cefixime Trihydrate
200 mg/5 ml, 50 ml and 100 ml Powder for Oral Suspension -
Product Cefpodoxime Proxetil
50 mg/5 ml, 100 mg/5 ml Powder for Oral Suspension -
Product Ceftriaxone Sodium
0.5, 1 g (IV) Injectable (vial) -
Product Ceftriaxone Sodium
0.5, 1 g (IM) Injectable (vial) -
Product Ceftriaxone Sodium
2 g (IV) /20 ml Injectable (vial) -
Product Cefuroxime Axetil
250, 500 mg Film Coated Tablet -
Product Cefuroxime Axetil
125 mg/5 ml, 50 ml and 100 ml Granule for Oral Suspension
Deva Holding A.S. resources (1)
-
Brochure Deva EU Markets Product List
Deva EU Markets Product List
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance